SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-24-000048
Filing Date
2024-05-01
Accepted
2024-05-01 07:00:25
Documents
17
Period of Report
2024-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20240501.htm   iXBRL 8-K 35122
2 EX-99.1 a2024q1exhibit9912.htm EX-99.1 250136
3 EX-99.2 a2024q1exhibit9922.htm EX-99.2 24225
8 logo.jpg GRAPHIC 17029
  Complete submission text file 0000200406-24-000048.txt   536031

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240501.xsd EX-101.SCH 3333
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240501_def.xml EX-101.DEF 16713
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240501_lab.xml EX-101.LAB 30867
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240501_pre.xml EX-101.PRE 17560
20 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240501_htm.xml XML 6219
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 24900007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)